Why the study?
How can drug compliance be assessed in patients with resistant hypertension to improve blood pressure control?
How can drug compliance be assessed in patients with resistant hypertension to improve blood pressure control?
Assessing medication adherence through various methods and early patient communication is crucial for managing resistant hypertension.
Answers are grounded in this paper and cite their sources.
Early adherence discussion plus out-of-office BP aids true resistant hypertension identification; leaves optimal methods open for prospective trials.
The persistence of high blood pressure under antihypertensive treatment (resistant hypertension) entails an increased cardiovascular risk. It occurs in three of ten treated hypertensive patients, and has several possible contributing factors, notably insufficient therapeutic adherence. There are a number of ways to evaluate whether patients take their medication as prescribed. These include interviewing the patient, pill counting, prescription follow-up, assay of drugs in blood or urine, and use of electronic pill dispensers. None is perfect. However, the essential is to discuss with the patient the importance of complying with the treatment as soon as it is prescribed for the first time, and not waiting for the appearance of resistant hypertension. The measurement of blood pressure outside the medical office and the monitoring of adherence may help to identify patients in whom hypertension is truly resistant and so to tailor the measures required to improve the control of blood pressure in the most appropriate manner.
No takes yet. Share an insight, caveat, or question.
Waeber et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: